Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1400 of 1463 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 06/22/23
Due: 06/22/24
Phase: N/A
Priority: Normal
Start: 05/10/17
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 01/01/10
End: 12/30/19
Due: 12/30/20
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 08/15/19
End: 08/01/21
Due: 08/01/22
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 03/31/17
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 05/10/25
End: 05/10/30
Due: 05/10/31
Phase: N/A
Priority: Normal
Start: 01/14/20
End: 02/28/22
Due: 02/28/23
S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 11/27/24
End: 11/20/29
Due: 11/20/30
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 07/17/24
Due: 07/17/25
Phase: N/A
Priority: Normal
Start: 12/31/21
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 01/30/21
End: 01/30/26
Due: 01/30/27
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 08/31/20
Due: 08/31/21
Phase: N/A
Priority: Normal
Start: 05/01/18
End: 05/01/21
Due: 05/01/22
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 10/04/21
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 04/05/24
End: 04/15/25
Due: 04/15/26
Phase: N/A
Priority: Normal
Start: 06/20/20
End: 06/20/21
Due: 06/20/22